BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11172011)

  • 1. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene.
    Ye X; Zhu C; Harper JW
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1682-6. PubMed ID: 11172011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
    Zariwala M; Liu J; Xiong Y
    Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis.
    Braun K; Hölzl G; Pusch O; Hengstschläger M
    DNA Cell Biol; 1998 Sep; 17(9):789-98. PubMed ID: 9778038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of a cyclin-like protein associated with cyclin-dependent kinase 3 (cdk 3) in vivo.
    Matsuoka M; Matsuura Y; Semba K; Nishimoto I
    Biochem Biophys Res Commun; 2000 Jul; 273(2):442-7. PubMed ID: 10873625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
    Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ
    Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression.
    Saxena UH; Powell CM; Fecko JK; Cacioppo R; Chou HS; Cooper GM; Hansen U
    Mol Cell Biol; 2009 May; 29(9):2335-45. PubMed ID: 19237534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ik3-1/Cables is a substrate for cyclin-dependent kinase 3 (cdk 3).
    Yamochi T; Semba K; Tsuji K; Mizumoto K; Sato H; Matsuura Y; Nishimoto I; Matsuoka M
    Eur J Biochem; 2001 Dec; 268(23):6076-82. PubMed ID: 11733001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex.
    Park M; Krause MW
    Development; 1999 Nov; 126(21):4849-60. PubMed ID: 10518501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.
    Fisher RP; Morgan DO
    Cell; 1994 Aug; 78(4):713-24. PubMed ID: 8069918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling and dynamics simulation of human cyclin-dependent kinase 3 complexed with inhibitors.
    Perez PC; Caceres RA; Canduri F; de Azevedo WF
    Comput Biol Med; 2009 Feb; 39(2):130-40. PubMed ID: 19152876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for cyclin-dependent kinases in cell cycle control.
    van den Heuvel S; Harlow E
    Science; 1993 Dec; 262(5142):2050-4. PubMed ID: 8266103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.
    Zheng D; Cho YY; Lau AT; Zhang J; Ma WY; Bode AM; Dong Z
    Cancer Res; 2008 Sep; 68(18):7650-60. PubMed ID: 18794154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases.
    Meikrantz W; Schlegel R
    J Biol Chem; 1996 Apr; 271(17):10205-9. PubMed ID: 8626584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.